Cell Counting Devices Market - Global Outlook & Forecast 2024-2029

317 pages

152 tables

113 charts

5 region

22 countries

67 company

4 segments

Purchase Options

$4200.00
$4999.00
$5999.00
$2000.00

Have a question?

Please get in touch with our team in case of any queries

+1-312-235-2040

THE GLOBAL CELL COUNTING DEVICES MARKET SIZE IS EXPECTED TO REACH USD 18.64 BILLION BY 2029 FROM USD 12.39 BILLION IN 2023, GROWING AT A CAGR OF 7.04% DURING THE FORECAST PERIOD.

The Cell Counting Devices Market Size, Share, & Trends Analysis Report By

  1. Product: Consumables and Instruments
  2. Applications: Research, Development, & Bioprocessing, Clinical Diagnostics, and Other Applications
  3. End-Users: Pharma & Biotech Companies, Diagnostics Laboratories, Research Institutes & Labs, CDMOs & CROs, and Other End-users
  4. Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

CELL COUNTING DEVICES MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2029)USD 18.64 Billion
Market Size (2023)USD 12.39 Billion
CAGR (2023-2029)7.04%
HISTORIC YEAR2020-2022
BASE YEAR2023
FORECAST YEAR2024-2029
SEGMENTS BYProduct, Applications, End-Users, and Geography
GEOGRAPHIC ANALYSIS North America, Europe, APAC, Latin America, and Middle East & Africa
KEY PLAYERSAbbott, Bio-Rad Laboratories, Boule, Danaher, Diatron, HORIBA, Merck KGaA, PerkinElmer, Siemens Healthineers, Sysmex Corporation, and Thermo Fisher Scientific
Interested in this Report?

Download a Sample!

INDUSTRY OVERVIEW

The global cell counting devices market was valued at USD 12.39 billion in 2023 and is expected to reach USD 18.64 billion by 2029, growing at a CAGR of 7.04% during the forecast period. The market has witnessed significant development in the past few years. Cell counting devices are essential for clinical and pharma & biotech industries, from research & development to final product development and manufacturing processes. The continued development of cell counters, from traditional and manual to automated, the integration of advanced tools and technologies, and the growth of the cell counting devices market have shown promising development in the coming years. Also, automated cell counting devices are changing the market landscape by offering several advantages over traditional ones. As the pharma, biotech, and healthcare industries are growing rapidly, their investment and understanding of automated cell counters are rising rapidly, accelerating market development.

MARKET TRENDS & DRIVERS

Technology Advancements in Cell Counting Devices

Cell counting is essential for biologists who work with/on cells for cell culture. Manual cell counting has been the most popular method in the past few decades and is commonly used across life sciences sectors. However, the development from manual to automated cell counting devices, integration and adoption of innovative technologies such as flow cytometry and image-based cell counting systems, and integration of new modules and tools are revolutionizing the cell counting devices market landscape and are expected to deliver significant growth opportunities. The most recent advancement, the introduction of image-based cell counters, delivers the benefits of continuous development of image analysis algorithms and machine learning for more consistent and faster counting. Certainly, computer-based image analysis helps detect features easily missed by the human eye. All these developments emerge rapidly as the industry develops with automated cell counting devices. These advanced systems lighten traditional methods' changeability, providing faster throughputs and superior accuracy.

Increasing Application Areas for Cell Counting Devices

Cell counting is an essential operation in several fields and industries. It is fundamental for research biologists who work with cells. From cell culture- seeding cells at adequate densities, monitoring cell health and proliferation, and facilitating proper passaging to vital for in-vitro experiments. Cell counting has become essential in several industries, from disease diagnosis to drug development and production, and has gained significant attention in the past few years. In pharmaceutical, academic, and industrial sectors, major factors, such as stem cell research, regenerative medicines, and personalized medicines, are trending factors closely associated with cell culture and analysis, which deliver lucrative opportunities for cell counting. Most biological applications work on cells, such as blood work, cell culture, and microbiology, expand the growth of the cell counting devices market. Also, the growing research across stem cell research and regenerative medicines offers lucrative opportunities for cell counting devices. In stem cell research and regenerative medicine development, the requirement of consistent cell counts to achieve successful work in research activities and cell counting devices play an essential role. In recent years, the rising attention in stem cell research across industry and academic sectors is due to cells' potential to alleviate and cure many health conditions.

Growing Burden of Chronic Disorders

The cell counting devices market is gaining popularity in the healthcare industry to diagnose, treat, and monitor several health conditions. Hospitals and clinics widely use cell counting devices to measure and determine patient health. In clinical diagnosis, hematology analysis of body fluids delivers valuable information and indicates clinical health conditions. The full blood count is regularly/routinely performed in health settings to measure diagnosis in health settings, which involves cell counting in blood samples. Moreover, the growing burden of chronic diseases boosts the demand for cell-counting devices. Cell counting is the most important consideration for cancer, autoimmune diseases, and CVD diseases, as well as for diagnosis, monitoring, and effective treatment delivery. Conversely, automated cell counting devices are recognized as vital to eliminating the extra workforce cost burden and monitoring development and manufacturing processes in drug discovery for these health conditions.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT 

The global cell counting devices market by product is segmented into consumables and instruments. The consumables segment holds the dominating segmental market share in 2023. The consumables in the cell counting procedures include assay, reagent, accessories, software analysis algorithms, assay kits, microplates, and accessories such as beads, slides, plates, and others. A broad range of consumables are used with cell counters that help optimize instrument setup, sampling preparation, and quality control. The application rate of cell-counting consumables is comparatively higher than that of instruments. Consumables are used and discarded, which demand continued investment that drives significant market growth.  

The instrument segment includes spectrophotometers, flow cytometers, hematology analyzers, manual cell counters/hemocytometers, automated cell counters, and Coulter counters. Cell counting devices, including manual and automated ones, are considered instruments in the study report. The growth of the segment heavily relies on technological advancements in cell counters. The available automated cell counters offer more precision and reduce the work burden and human errors. The popularity of automated cell counters is accelerating segmental growth. Furthermore, automated cell counters offer higher throughput and become an alternative to other cell counter instruments; apart from that, the rising preference for flow cytometers, spectrophotometers, and Coulter counters positively influences segmental growth. The industry has many cell-counting devices, and they all work differently. The rising application areas for cell counters, from healthcare to breweries and dairy industries, have boosted the market share significantly. 

INSIGHTS BY APPLICATION

The global cell counting devices market by applications is segmented into research, development, & bioprocessing, clinical diagnostics, and other applications. The research, development, & bioprocessing segment holds the most significant share of the global market in 2023. The rapidly growing research, development, and bioprocessing activities across the life sciences are accelerating segmental growth. Furthermore, the growing application of cell counters in the medical field across disease diagnosis and associated activities are some of the leading factors propelling clinical diagnostics segmental growth.

INSIGHTS BY END-USERS

The global cell counting devices market by end-users is segmented into pharma & biotech companies, diagnostics laboratories, research institutes & labs, CDMOs & CROs, and other end-users. By end-users, the pharma & biotech companies accounted for most of the segmental market share in 2023. Pharma and biotech companies that are highly investing in the R&D of novel drugs and therapies widely perform research studies. Cell counting devices play a major role in developing cell and gene-based therapies, regenerative medicines, advanced biologics, vaccines, and others that require the study of various cells, where cell counters are most commonly used by pharma & biotech companies.

GEOGRAPHICAL ANALYSIS

North America dominated the global cell counting devices market share, accounting for a global share of over 36% in 2023. The region is dominating the global market with the rise in the aging population, prevalence of chronic diseases, increasing healthcare expenditure, need for advanced healthcare, presence of well-established players, and a major shift towards automation in cell counting devices. Most importantly, the presence of several manufacturers producing automated cell counting equipment with a wide range of products according to the margin of affordability contributes to the region’s highest share in the global market. Furthermore, in North America, the U.S. is a major market landscape that achieves the highest revenue growth for cell counting devices compared to other countries worldwide.

Europe holds a significant position in the global cell counting devices market in 2023. In Europe, a significant patient population with chronic diseases raises research and development activities across life sciences industries, delivering lucrative market growth opportunities. Furthermore, the growing research across cell and gene therapies, stem cells, and regenerative medicines drives the region's demand for automated cell counters. Also, APAC will likely be the fastest-growing region in the global cell counting devices market during the forecast period. This is mostly due to the growing aging population in need of diagnosis and treatment, the rise in prevalence of chronic diseases, demand for high-quality healthcare, growing healthcare infrastructure, and most importantly, the increasing number of healthcare centers such as hospitals, clinics, diagnostics centers, laboratories, and others.

VENDOR LANDSCAPE

The global cell counting devices market is exceptionally active, with several global, regional, and local players offering various cell counters. Also, the hematology analyzers used for cell analysis and counting significantly influence vendor competition. Several leading hematology analyzer companies compete with cell counting device manufacturing companies. The market is increasingly competitive, and vendors are highly focused on making partnerships and collaborations to maintain a competitive edge over other players. For instance, in 2022, Merck KGaA made a research collaboration and commercial license agreement with Mersana Therapeutics to discover novel antibody-drug conjugates.

Key players account for the major share of the global cell counting devices market. These key vendors include Abbott, Bio-Rad Laboratories, Boule, Danaher, Diatron, Merck KGaA, Horiba, Thermo Fisher Scientific, PerkinElmer, Siemens Healthineers, and Sysmex Corporation. Abbott offers high-quality hematology analyzers in the cell counting devices industry that meet a broad range of cell counting requirements. Abbott offers various medical diagnostics instruments, tests, automation, informatics, and solutions for multiple end-users. In 2018, Abbott strengthened its position in diagnostics by introducing Alinity, a separate platform for laboratory operations, tests, and services. Abbott has a complete portfolio of hematology solutions for cell count procedures, including automated analyzers, slide-maker strainers, reagents, calibrators, and controls for laboratories with diverse testing volumes. CELL-DYN Emerald 22 is the latest hematology analyzer introduced by Abbott.

Frequently Asked Questions

What is the growth rate of the global cell counting devices market?

The global cell counting devices market is expected to grow at a CAGR of 7.04% from 2023 to 2029.

How big is the cell counting devices market?

The global cell counting devices market size was valued at USD 12.39 billion in 2023 and is expected to reach USD 18.64 billion by 2029.

What are the significant trends in the cell counting devices industry?

Technology advancements in cell counting devices, increasing application areas for cell counting devices, and the rising focus on flow cytometry in cell counting are significant trends in the cell counting devices industry.

Which region dominates the global cell counting devices market share?

North America held the largest global cell counting devices market share, accounting for a share of over 36% in 2023.

Who are the key players in the global cell counting devices market?

Abbott, Bio-Rad Laboratories, Boule, Danaher, Diatron, HORIBA, Merck KGaA, PerkinElmer, Siemens Healthineers, Sysmex Corporation, and Thermo Fisher Scientific are the key players in the global cell counting devices market.

The global cell counting devices market size is expected to grow at a CAGR of approximately 7.04% from 2023 to 2029.

The following factors are likely to contribute to the growth of the global cell counting devices market during the forecast period:

  1. Growing Burden of the Chronic Disorders
  2. Rapid Shift from Manual to the Automated Cell Counting Devices
  3. Continuously Increasing Research and Drug Discovery Activities

Base Year: 2023

Forecast Year: 2024-2029

The report considers the present scenario of the global cell counting devices market and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.

Key Company Profiles

  1. AbbottBusiness
  2. Overview
  3. Product Offerings
  4. Key Strategies
  5. Key Strengths
  6. Key Opportunities
  7. Bio-Rad Laboratories
  8. Boule
  9. Danaher
  10. Diatron
  11. HORIBA
  12. Merck KGaA
  13. PerkinElmer
  14. Siemens Healthineers
  15. Sysmex Corporation
  16. Thermo Fisher Scientific

Other Prominent Vendors

  1. Advanced Instruments
  2. Business Overview
  3. Product Offerings
  4. Agilent Technologies
  5. Axion BioSystems
  6. Aligned Genetics (Logos Biosystems)
  7. Alphatec Scientific
  8. Agappe Diagnostics
  9. Analyticon Biotechnologies
  10. Balio Diagnostics
  11. B&E BIO-TECHNOLOGY
  12. BioSystems Diagnostics
  13. Bioway Biological Technology
  14. BIOSYSY Scientific Devices GmbH
  15. Benchmark Scientific
  16. BD
  17. Bruker Spatial Biology (NanoString Technologies, Inc.)
  18. Bentley Instruments
  19. ChemoMetec
  20. Corning Incorporated
  21. Curiosis Inc
  22. Cytek Biosciences
  23. Cole-Parmer Instrument Company
  24. Cellular Technology Limited (Immunospot)
  25. CLINDIAG SYSTEMS
  26. CONTECH MEDICAL SYSTEMS
  27. Convergent Technologies
  28. CPC Diagnostics
  29. DIAGON
  30. Dirui
  31. Drucker Diagnostics
  32. DeNovix
  33. EDAN Instruments
  34. F. Hoffmann-La Roche
  35. Genrui Biotech
  36. High Technology
  37. Hospitex International Ltd
  38. LINEAR CHEMICALS
  39. Maccura Biotechnology
  40. Meril Life Sciences
  41. Medsource Ozone Biomedicals
  42. NIHON KOHDEN CORPORATION
  43. Norma Instruments
  44. NanoEntek
  45. Paul Marienfeld GmbH & Co. KG
  46. RWD Life Sciences Co., LTD.
  47. Revvity
  48. Sartorius AG
  49. Shenzhen Mindray Bio-Medical Electronics
  50. Shenzhen Landwind Industry
  51. Prestige Diagnostics
  52. SFRI
  53. Shenzhen Dymind Biotechnology
  54. Shenzhen Prokan Electronics
  55. SPINREACT
  56. Trivitron Healthcare
  57. Tecan Trading Ag
  58. Tip Biosystems

Segmentation by Product

  1. Consumables
  2. Instruments

Segmentation by Applications

  1. Research, Development, & Bioprocessing
  2. Clinical Diagnostics
  3. Other Applications

Segmentation by End-Users

  1. Pharma & Biotech Companies
  2. Diagnostics Laboratories
  3. Research Institutes & Labs
  4. CDMOs & CROs
  5. Other End-users

Segmentation by Geography

  1. North America
  2. The U.S.
  3. Canada
  4. Europe
  5. Germany
  6. France
  7. The U.K.
  8. Italy
  9. Spain
  10. Russia
  11. Poland
  12. APAC
  13. China
  14. Japan
  15. India
  16. South Korea
  17. Australia
  18. Indonesia
  19. Latin America
  20. Brazil
  21. Mexico
  22. Argentina
  23. Middle East & Africa
  24. Turkey
  25. Saudi Arabia
  26. South Africa
  27. UAE

LIST OF EXHIBITS


EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023

EXHIBIT 2 CELL COUNTING DEVICES: MARKET DYNAMICS

EXHIBIT 3 IMPACT OF TECHNOLOGICAL ADVANCES IN CELL COUNTING DEVICES

EXHIBIT 4 MOST RECENT TECHNOLOGICAL ADVANCES IN CELL COUNTING DEVICES:

EXHIBIT 5 OUTCOMES OF LEVERAGING VISUAL AI FOR CELL COUNTING

EXHIBIT 6 IMPACT OF INCREASING APPLICATION AREAS FOR CELL COUNTING DEVICES

EXHIBIT 7 IMPACT OF RISING FOCUS ON FLOW CYTOMETRY IN CELL COUNTING

EXHIBIT 8 FACTORS ENABLING FLOW CYTOMETRY IN CELL COUNTING

EXHIBIT 9 IMPACT OF GROWING BURDEN OF CHRONIC DISORDERS

EXHIBIT 10 GLOBAL CANCER CASES BY TYPE 2021

EXHIBIT 11 IMPACT OF RAPID SHIFT FROM MANUAL TO AUTOMATED CELL COUNTING DEVICES

EXHIBIT 12 IMPACT OF EXPANSION OF APPLICATION AREAS IN RESEARCH AND DRUG DISCOVERY ACTIVITIES

EXHIBIT 13 IMPACT OF CHALLENGES ASSOCIATED WITH CELL COUNTING

EXHIBIT 14 IMPACT OF COST OF CELL COUNTING DEVICES

EXHIBIT 15 IMPACT OF LACK OF EXPERTISE, AUTOMATION, & HUMAN ERRORS

EXHIBIT 16 GLOBAL CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH BY GEOGRAPHY

EXHIBIT 17 CELL COUNTING DEVICES MARKET SEGMENTATION

EXHIBIT 18 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT: SHARE ANALYSIS 2023 & 2029 (%)

EXHIBIT 19 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION: SHARE ANALYSIS 2023 & 2029 (%)

EXHIBIT 20 GLOBAL CELL COUNTING DEVICES MARKET BY END-USERS: SHARE ANALYSIS 2023 & 2029 (%)

EXHIBIT 21 GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY: SHARE ANALYSIS 2023 & 2029 (%)

EXHIBIT 22 GLOBAL CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)

EXHIBIT 23 FIVE FORCES ANALYSIS 2023

EXHIBIT 24 INCREMENTAL GROWTH BY PRODUCT 2023 & 2029

EXHIBIT 25 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT 2023-2029

EXHIBIT 26 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 27 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT: ABSOLUTE GROWTH (%)

EXHIBIT 28 GLOBAL CELL COUNTING CONSUMABLES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 29 GLOBAL CELL COUNTING CONSUMABLES MARKET 2023–2029 ($ BILLION)

EXHIBIT 30 GLOBAL CELL COUNTING INSTRUMENTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 31 GLOBAL CELL COUNTING INSTRUMENTS MARKET 2023–2029 ($ BILLION)

EXHIBIT 32 INCREMENTAL GROWTH BY APPLICATION 2023 & 2029

EXHIBIT 33 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION 2023-2029

EXHIBIT 34 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 35 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION: ABSOLUTE GROWTH (%)

EXHIBIT 36 CELL & GENE THERAPIES STATISTICS

EXHIBIT 37 GLOBAL RESEARCH, DEVELOPMENT & BIOPROCESSING CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 38 GLOBAL RESEARCH, DEVELOPMENT, AND BIOPROCESSING CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)

EXHIBIT 39 GLOBAL CLINICAL DIAGNOSTICS CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 40 GLOBAL CLINICAL DIAGNOSTICS CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)

EXHIBIT 41 GLOBAL OTHER APPLICATIONS CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 42 GLOBAL OTHER APPLICATIONS CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)

EXHIBIT 43 INCREMENTAL GROWTH BY END-USERS 2023 & 2029

EXHIBIT 44 GLOBAL CELL COUNTING DEVICES MARKET BY END-USERS 2023-2029

EXHIBIT 45 GLOBAL CELL COUNTING DEVICES MARKET BY END-USERS: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 46 GLOBAL CELL COUNTING DEVICES MARKET BY END-USERS: ABSOLUTE GROWTH (%)

EXHIBIT 47 APPLICATION AREAS FOR CELL COUNTERS IN PHARMA & BIOTECH COMPANIES

EXHIBIT 48 GLOBAL PHARMA & BIOTECH COMPANIES CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 49 GLOBAL PHARMA & BIOTECH COMPANIES CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)

EXHIBIT 50 GLOBAL DIAGNOSTICS LABORATORIES CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 51 GLOBAL DIAGNOSTICS LABORATORIES CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)

EXHIBIT 52 GLOBAL RESEARCH INSTITUTES & LABS CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 53 GLOBAL RESEARCH INSTITUTES & LABS CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)

EXHIBIT 54 GLOBAL CDMOS & CROS CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 55 GLOBAL CDMOS & CROS CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)

EXHIBIT 56 GLOBAL OTHER END-USERS: CELL COUNTING DEVICES MARKET INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 57 GLOBAL OTHER END-USERS CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)

EXHIBIT 58 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029

EXHIBIT 59 THE GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023-2029

EXHIBIT 60 GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH

EXHIBIT 61 GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH

EXHIBIT 62 CELL COUNTING DEVICES MARKET IN NORTH AMERICA: KEY COUNTRIES REVENUE ($ BILLION) 2023

EXHIBIT 63 CELL COUNTING DEVICES MARKET IN NORTH AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 64 CELL COUNTING DEVICES MARKET IN NORTH AMERICA 2023–2029 ($ BILLION)

EXHIBIT 65 INCREMENTAL GROWTH IN NORTH AMERICA 2023 & 2029

EXHIBIT 66 CHRONIC DISEASES BURDEN IN THE US 2023

EXHIBIT 67 CELL COUNTING DEVICES MARKET IN US 2023–2029 ($ BILLION)

EXHIBIT 68 CHRONIC DISEASES BURDEN IN CANADA 2020

EXHIBIT 69 CELL COUNTING DEVICES MARKET IN CANADA 2023–2029 ($ BILLION)

EXHIBIT 70 CELL COUNTING DEVICES MARKET IN EUROPE: KEY COUNTRIES REVENUE ($ BILLION) 2023

EXHIBIT 71 CELL COUNTING DEVICES MARKET IN EUROPE: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 72 CELL COUNTING DEVICES MARKET IN EUROPE 2023–2029 ($ BILLION)

EXHIBIT 73 INCREMENTAL GROWTH IN EUROPE 2023 & 2029

EXHIBIT 74 CHRONIC DISEASES BURDEN IN GERMANY 2022

EXHIBIT 75 CELL COUNTING DEVICES MARKET IN GERMANY 2023–2029 ($ BILLION)

EXHIBIT 76 CELL COUNTING DEVICES MARKET IN FRANCE 2023–2029 ($ BILLION)

EXHIBIT 77 ESTIMATED AND PREDICTED CANCER BURDEN IN THE UK (CASES IN MILLION) 2020-2040

EXHIBIT 78 CELL COUNTING DEVICES MARKET IN UK 2023–2029 ($ BILLION)

EXHIBIT 79 CELL COUNTING DEVICES MARKET IN ITALY 2023–2029 ($ BILLION)

EXHIBIT 80 CELL COUNTING DEVICES MARKET IN SPAIN 2023–2029 ($ BILLION)

EXHIBIT 81 CELL COUNTING DEVICES MARKET IN RUSSIA 2023–2029 ($ BILLION)

EXHIBIT 82 CELL COUNTING DEVICES MARKET IN POLAND 2023–2029 ($ BILLION)

EXHIBIT 83 CELL COUNTING DEVICES MARKET IN APAC: KEY COUNTRIES REVENUE ($ BILLION) 2023

EXHIBIT 84 CELL COUNTING DEVICES MARKET IN APAC: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 85 CELL COUNTING DEVICES MARKET IN APAC 2023–2029 ($ BILLION)

EXHIBIT 86 INCREMENTAL GROWTH IN APAC 2023 & 2029

EXHIBIT 87 CELL COUNTING DEVICES MARKET IN CHINA 2023–2029 ($ BILLION)

EXHIBIT 88 CELL COUNTING DEVICES MARKET IN JAPAN 2023–2029 ($ BILLION)

EXHIBIT 89 CANCER PREVALENCE IN INDIA: ESTIMATED & PREDICTED PREVALENCE (MILLION) 2018–2025

EXHIBIT 90 CELL COUNTING DEVICES MARKET IN INDIA 2023–2029 ($ BILLION)

EXHIBIT 91 CELL COUNTING DEVICES MARKET IN SOUTH KOREA 2023–2029 ($ BILLION)

EXHIBIT 92 CELL COUNTING DEVICES MARKET IN AUSTRALIA 2023–2029 ($ BILLION)

EXHIBIT 93 CELL COUNTING DEVICES MARKET IN INDONESIA 2023–2029 ($ BILLION)

EXHIBIT 94 CELL COUNTING DEVICES MARKET IN LATIN AMERICA: KEY COUNTRIES REVENUE ($ BILLION) 2023

EXHIBIT 95 CELL COUNTING DEVICES MARKET IN LATIN AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 96 CELL COUNTING DEVICES MARKET IN LATIN AMERICA 2023–2029 ($ BILLION)

EXHIBIT 97 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029

EXHIBIT 98 CELL COUNTING DEVICES MARKET IN BRAZIL 2023–2029 ($ BILLION)

EXHIBIT 99 CELL COUNTING DEVICES MARKET IN MEXICO 2023–2029 ($ BILLION)

EXHIBIT 100 CELL COUNTING DEVICES MARKET IN ARGENTINA 2023–2029 ($ BILLION)

EXHIBIT 101 CELL COUNTING DEVICES MARKET IN MEA: KEY COUNTRIES REVENUE ($ BILLION) 2023

EXHIBIT 102 CELL COUNTING DEVICES MARKET IN MEA: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 103 CELL COUNTING DEVICES MARKET IN MEA 2023–2029 ($ BILLION)

EXHIBIT 104 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2023 & 2029

EXHIBIT 105 CELL COUNTING DEVICES MARKET IN TURKEY 2023–2029 ($ BILLION)

EXHIBIT 106 CELL COUNTING DEVICES MARKET IN SAUDI ARABIA 2023–2029 ($ BILLION)

EXHIBIT 107 CELL COUNTING DEVICES MARKET IN SOUTH AFRICA 2023–2029 ($ BILLION)

EXHIBIT 108 CELL COUNTING DEVICES MARKET IN UAE 2023–2029 ($ BILLION)

EXHIBIT 109 MARKET DOMINANCE ANALYSIS OF VENDORS OFFERING CELL COUNTING DEVICES

EXHIBIT 110 CAPABILITIES & EXPERT ASSESSMENT OF VENDORS OFFERING CELL COUNTING DEVICES

EXHIBIT 111 KEY CAVEATS


LIST OF TABLES


TABLE 1 SOME EXAMPLES OF CELL COUNTING REAGENTS

TABLE 2 SOME EXAMPLES OF CELL COUNTING BEADS

TABLE 3 SOFTWARE FOR CELL COUNTERS

TABLE 4 GLOBAL CELL COUNTING CONSUMABLES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)

TABLE 5 GLOBAL CELL COUNTING CONSUMABLES MARKET BY GEOGRAPHY 2023−2029 (%)

TABLE 6 GLOBAL CELL COUNTING INSTRUMENTS MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)

TABLE 7 GLOBAL CELL COUNTING INSTRUMENTS MARKET BY GEOGRAPHY 2023−2029 (%)

TABLE 8 GLOBAL RESEARCH, DEVELOPMENT, AND BIOPROCESSING CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)

TABLE 9 GLOBAL RESEARCH, DEVELOPMENT, AND BIOPROCESSING CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)

TABLE 10 GLOBAL CLINICAL DIAGNOSTICS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)

TABLE 11 GLOBAL CLINICAL DIAGNOSTICS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)

TABLE 12 GLOBAL OTHER APPLICATIONS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)

TABLE 13 GLOBAL OTHER APPLICATIONS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)

TABLE 14 CELL COUNTING DEVICES MAJOR APPLICATIONS IN PHARMA & BIOTECH COMPANIES

TABLE 15 GLOBAL PHARMA & BIOTECH COMPANIES CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)

TABLE 16 GLOBAL PHARMA & BIOTECH COMPANIES CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)

TABLE 17 GLOBAL DIAGNOSTICS LABORATORIES CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)

TABLE 18 GLOBAL DIAGNOSTICS LABORATORIES CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)

TABLE 19 GLOBAL RESEARCH INSTITUTES & LABS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)

TABLE 20 GLOBAL RESEARCH INSTITUTES & LABS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)

TABLE 21 SOME MAJOR CELL & GENE THERAPY CROS & CDMOS (2022 & 2023)

TABLE 22 GLOBAL CDMOS & CROS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)

TABLE 23 GLOBAL CDMOS & CROS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)

TABLE 24 GLOBAL OTHER END-USERS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)

TABLE 25 GLOBAL OTHER END-USERS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)

TABLE 26 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY PRODUCT 2023−2029 ($ BILLION)

TABLE 27 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY PRODUCT 2023−2029 (%)

TABLE 28 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY APPLICATION 2023−2029 ($ BILLION)

TABLE 29 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY APPLICATION 2023−2029 (%)

TABLE 30 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY END-USERS 2023−2029 ($ BILLION)

TABLE 31 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY END-USERS 2023−2029 (%)

TABLE 32 CELL COUNTING DEVICES MARKET IN EUROPE BY PRODUCT 2023−2029 ($ BILLION)

TABLE 33 CELL COUNTING DEVICES MARKET IN EUROPE BY PRODUCT 2023−2029 (%)

TABLE 34 CELL COUNTING DEVICES MARKET IN EUROPE BY APPLICATION 2023−2029 ($ BILLION)

TABLE 35 CELL COUNTING DEVICES MARKET IN EUROPE BY APPLICATION 2023−2029 (%)

TABLE 36 CELL COUNTING DEVICES MARKET IN EUROPE BY END-USERS 2023−2029 ($ BILLION)

TABLE 37 CELL COUNTING DEVICES MARKET IN EUROPE BY END-USERS 2023−2029 (%)

TABLE 38 CANCER CASES DIAGNOSED IN THE UK

TABLE 39 CELL COUNTING DEVICES MARKET IN APAC BY PRODUCT 2023−2029 ($ BILLION)

TABLE 40 CELL COUNTING DEVICES MARKET IN APAC BY PRODUCT 2023−2029 (%)

TABLE 41 CELL COUNTING DEVICES MARKET IN APAC BY APPLICATION 2023−2029 ($ BILLION)

TABLE 42 CELL COUNTING DEVICES MARKET IN APAC BY APPLICATION 2023−2029 (%)

TABLE 43 CELL COUNTING DEVICES MARKET IN APAC BY END-USERS 2023−2029 ($ BILLION)

TABLE 44 CELL COUNTING DEVICES MARKET IN APAC BY END-USERS 2023−2029 (%)

TABLE 45 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY PRODUCT 2023−2029 ($ BILLION)

TABLE 46 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY PRODUCT 2023−2029 (%)

TABLE 47 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY APPLICATION 2023−2029 ($ BILLION)

TABLE 48 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY APPLICATION 2023−2029 (%)

TABLE 49 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY END-USERS 2023−2029 ($ BILLION)

TABLE 50 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY END-USERS 2023−2029 (%)

TABLE 51 CELL COUNTING DEVICES MARKET IN MEA BY PRODUCT 2023−2029 ($ BILLION)

TABLE 52 CELL COUNTING DEVICES MARKET IN MEA BY PRODUCT 2023−2029 (%)

TABLE 53 CELL COUNTING DEVICES MARKET IN MEA BY APPLICATION 2023−2029 ($ BILLION)

TABLE 54 CELL COUNTING DEVICES MARKET IN MEA BY APPLICATION 2023−2029 (%)

TABLE 55 CELL COUNTING DEVICES MARKET IN MEA BY END-USERS 2023−2029 ($ BILLION)

TABLE 56 CELL COUNTING DEVICES MARKET IN MEA BY END-USERS 2023−2029 (%)

TABLE 57 ABBOTT: MAJOR PRODUCT OFFERINGS

TABLE 58 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS

TABLE 59 BOULE: MAJOR PRODUCT OFFERINGS

TABLE 60 DANAHER: MAJOR PRODUCT OFFERINGS

TABLE 61 DIATRON: MAJOR PRODUCT OFFERINGS

TABLE 62 HORIBA: MAJOR PRODUCT OFFERINGS

TABLE 63 MERCK KGAA: MAJOR PRODUCT OFFERINGS

TABLE 64 PERKINELMER: MAJOR PRODUCT OFFERINGS

TABLE 65 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS

TABLE 66 SYSMEX CORPORATION: MAJOR PRODUCT OFFERINGS

TABLE 67 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS

TABLE 68 ADVANCED INSTRUMENTS: MAJOR PRODUCT OFFERINGS

TABLE 69 AGILENT TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 70 AXION BIOSYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 71 ALIGNED GENETICS: MAJOR PRODUCT OFFERINGS

TABLE 72 ALPHATEC SCIENTIFIC: MAJOR PRODUCT OFFERINGS

TABLE 73 AGAPPE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 74 ANALYTICON BIOTECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 75 BALIO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 76 B&E BIO-TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 77 BIOSYSTEMS DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 78 BIOWAY BIOLOGICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 79 BIOSYSY SCIENTIFIC DEVICES GMBH: MAJOR PRODUCT OFFERINGS

TABLE 80 BENCHMARK SCIENTIFIC: MAJOR PRODUCT OFFERINGS

TABLE 81 BD: MAJOR PRODUCT OFFERINGS

TABLE 82 BRUKER SPATIAL BIOLOGY (NANOSTRING TECHNOLOGIES, INC.): MAJOR PRODUCT OFFERINGS

TABLE 83 BENTLEY INSTRUMENTS: MAJOR PRODUCT OFFERINGS

TABLE 84 CHEMOMETEC: MAJOR PRODUCT OFFERINGS

TABLE 85 CORNING INCORPORATED: MAJOR PRODUCT OFFERINGS

TABLE 86 CURIOSIS INC: MAJOR PRODUCT OFFERINGS

TABLE 87 CYTEK BIOSCIENCES: MAJOR PRODUCT OFFERINGS

TABLE 88 COLE-PARMER INSTRUMENT COMPANY: MAJOR PRODUCT OFFERINGS

TABLE 89 CELLULAR TECHNOLOGY LIMITED: MAJOR PRODUCT OFFERINGS

TABLE 90 CLINDIAG SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 91 CONTECH MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 92 CONVERGENT TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 93 CPC DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 94 DIAGON: MAJOR PRODUCT OFFERINGS

TABLE 95 DIRUI: MAJOR PRODUCT OFFERINGS

TABLE 96 DRUCKER DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 97 DENOVIX: MAJOR PRODUCT OFFERINGS

TABLE 98 EDAN INSTRUMENTS: MAJOR PRODUCT OFFERINGS

TABLE 99 F. HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS

TABLE 100 GENRUI BIOTECH: MAJOR PRODUCT OFFERINGS

TABLE 101 HIGH TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 102 HOSPITEX INTERNATIONAL LTD: MAJOR PRODUCT OFFERINGS

TABLE 103 LINEAR CHEMICALS: MAJOR PRODUCT OFFERINGS

TABLE 104 MACCURA BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 105 MERIL LIFE SCIENCES: MAJOR PRODUCT OFFERINGS

TABLE 106 MEDSOURCE OZONE BIOMEDICALS: MAJOR PRODUCT OFFERINGS

TABLE 107 NIHON KOHDEN CORPORATION: MAJOR PRODUCT OFFERINGS

TABLE 108 NORMA INSTRUMENTS: MAJOR PRODUCT OFFERINGS

TABLE 109 NANOENTEK: MAJOR PRODUCT OFFERINGS

TABLE 110 PAUL MARIENFELD GMBH & CO. KG: MAJOR PRODUCT OFFERINGS

TABLE 111 RWD LIFE SCIENCES CO. LTD: MAJOR PRODUCT OFFERINGS

TABLE 112 REVVITY: MAJOR PRODUCT OFFERINGS

TABLE 113 SARTORIUS AG: MAJOR PRODUCT OFFERINGS

TABLE 114 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS: MAJOR PRODUCT OFFERINGS

TABLE 115 SHENZHEN LANDWIND INDUSTRY: MAJOR PRODUCT OFFERINGS

TABLE 116 PRESTIGE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 117 SFRI: MAJOR PRODUCT OFFERINGS

TABLE 118 SHENZHEN DYMIND BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 119 SHENZHEN PROKAN ELECTRONICS: MAJOR PRODUCT OFFERINGS

TABLE 120 SPINREACT: MAJOR PRODUCT OFFERINGS

TABLE 121 TRIVITRON HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 122 TECAN TRADING AG: MAJOR PRODUCT OFFERINGS

TABLE 123 TIP BIOSYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 124 GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)

TABLE 125 GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)

TABLE 126 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT 2023−2029 ($ BILLION)

TABLE 127 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT 2023−2029 (%)

TABLE 128 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION 2023−2029 ($ BILLION)

TABLE 129 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION 2023−2029 (%)

TABLE 130 GLOBAL CELL COUNTING DEVICES MARKET BY END-USERS 2023−2029 ($ BILLION)

TABLE 131 GLOBAL CELL COUNTING DEVICES MARKET BY END-USER 2023−2029 (%)

TABLE 132 CURRENCY CONVERSION 2016−2023

1 SCOPE & COVERAGE

1.1. MARKET DEFINITION

1.1.1. INCLUSIONS

1.1.2. EXCLUSIONS

1.1.3. MARKET ESTIMATION CAVEATS

1.2. MARKET SEGMENTATION

1.2.1. MARKET BY PRODUCT

1.2.2. MARKET BY APPLICATIONS

1.2.3. MARKET BY END-USERS

1.2.4. REGIONS & COUNTRIES COVERED

1.3. MARKET DERIVATION

1.3.1. HISTORIC PERIOD, BASE YEAR, & FORECAST YEARS

2 PREMIUM INSIGHTS

2.1 OPPORTUNITY POCKETS

2.2 OVERVIEW

3 MARKET AT A GLANCE

4 INTRODUCTION

4.1. OVERVIEW

5 MARKET OPPORTUNITIES & TRENDS

5.1. TECHNOLOGICAL ADVANCES IN CELL COUNTING DEVICES

5.2. INCREASING APPLICATION AREAS FOR CELL COUNTING DEVICES

5.3. RISING FOCUS ON FLOW CYTOMETRY IN CELL COUNTING

6 MARKET GROWTH ENABLERS

6.1 GROWING BURDEN OF CHRONIC DISORDERS

6.2 RAPID SHIFT FROM MANUAL TO AUTOMATED CELL COUNTING DEVICES

6.3 EXPANSION OF APPLICATION AREAS IN RESEARCH AND DRUG DISCOVERY ACTIVITIES

7 MARKET RESTRAINTS

7.1 CHALLENGES ASSOCIATED WITH CELL COUNTING

7.2 COST OF CELL COUNTING DEVICES

7.3 LACK OF EXPERTISE, AUTOMATION, & HUMAN ERRORS

8 MARKET LANDSCAPE

8.1. MARKET OVERVIEW

8.1.1. BY PRODUCT: SEGMENT INSIGHTS

8.1.2. BY APPLICATION: SEGMENT INSIGHTS

8.1.3. BY END-USERS: SEGMENT INSIGHTS

8.1.4. BY GEOGRAPHY: SEGMENT INSIGHTS

8.2. MARKET SIZE & FORECAST

8.3. FIVE FORCES ANALYSIS

8.3.1. THREAT OF NEW ENTRANTS

8.3.2. BARGAINING POWER OF SUPPLIERS

8.3.3. BARGAINING POWER OF BUYERS

8.3.4. THREAT OF SUBSTITUTES

8.3.5. COMPETITIVE RIVALRY

9 PRODUCT

9.1. MARKET SNAPSHOT & GROWTH ENGINE

9.2. MARKET OVERVIEW

9.3. CONSUMABLES

9.3.1. MARKET OVERVIEW

9.3.2. MARKET SIZE & FORECAST

9.3.3. MARKET BY GEOGRAPHY

9.4. INSTRUMENTS

9.4.1. MARKET OVERVIEW

9.4.2. MARKET SIZE & FORECAST

9.4.3. MARKET BY GEOGRAPHY

10 APPLICATION

10.1. MARKET SNAPSHOT & GROWTH ENGINE

10.2. MARKET OVERVIEW

10.3. RESEARCH, DEVELOPMENT, & BIOPROCESSING

10.3.1. MARKET OVERVIEW

10.3.2. MARKET SIZE & FORECAST

10.3.3. MARKET BY GEOGRAPHY

10.4. CLINICAL DIAGNOSTICS

10.4.1. MARKET OVERVIEW

10.4.2. MARKET SIZE & FORECAST

10.4.3. MARKET BY GEOGRAPHY

10.5. OTHER APPLICATIONS

10.5.1. MARKET OVERVIEW

10.5.2. MARKET SIZE & FORECAST

10.5.3. MARKET BY GEOGRAPHY

11 END-USERS

11.1. MARKET SNAPSHOT & GROWTH ENGINE

11.2. MARKET OVERVIEW

11.3. PHARMA & BIOTECH COMPANIES

11.3.1. MARKET OVERVIEW

11.3.2. MARKET SIZE & FORECAST

11.3.3. MARKET BY GEOGRAPHY

11.4. DIAGNOSTIC LABORATORIES

11.4.1. MARKET OVERVIEW

11.4.2. MARKET SIZE & FORECAST

11.4.3. MARKET BY GEOGRAPHY

11.5. RESEARCH INSTITUTES & LABS

11.5.1. MARKET OVERVIEW

11.5.2. MARKET SIZE & FORECAST

11.5.3. MARKET BY GEOGRAPHY

11.6. CDMOS & CROS

11.6.1. MARKET OVERVIEW

11.6.2. MARKET SIZE & FORECAST

11.6.3. MARKET BY GEOGRAPHY

11.7. OTHER END-USERS

11.7.1. MARKET OVERVIEW

11.7.2. MARKET SIZE & FORECAST

11.7.3. MARKET BY GEOGRAPHY

12 GEOGRAPHY

12.1. MARKET SNAPSHOT & GROWTH ENGINE

12.2. GEOGRAPHIC OVERVIEW

13 NORTH AMERICA

13.1. MARKET OVERVIEW

13.2. MARKET SIZE & FORECAST

13.3. PRODUCT

13.3.1. MARKET SIZE & FORECAST

13.4. APPLICATION

13.4.1. MARKET SIZE & FORECAST

13.5. END-USERS

13.5.1. MARKET SIZE & FORECAST

13.6. KEY COUNTRIES

13.6.1. US: MARKET SIZE & FORECAST

13.6.2. CANADA: MARKET SIZE & FORECAST

14 EUROPE

14.1. MARKET OVERVIEW

14.2. MARKET SIZE & FORECAST

14.3. PRODUCT

14.3.1. MARKET SIZE & FORECAST

14.4. APPLICATION

14.4.1. MARKET SIZE & FORECAST

14.5. END-USERS

14.5.1. MARKET SIZE & FORECAST

14.6. KEY COUNTRIES

14.6.1. GERMANY: MARKET SIZE & FORECAST

14.6.2. FRANCE: MARKET SIZE & FORECAST

14.6.3. UK: MARKET SIZE & FORECAST

14.6.4. ITALY: MARKET SIZE & FORECAST

14.6.5. SPAIN: MARKET SIZE & FORECAST

14.6.6. RUSSIA: MARKET SIZE & FORECAST

14.6.7. POLAND: MARKET SIZE & FORECAST

15 APAC

15.1. MARKET OVERVIEW

15.2. MARKET SIZE & FORECAST

15.3. PRODUCT

15.3.1. MARKET SIZE & FORECAST

15.4. APPLICATION

15.4.1. MARKET SIZE & FORECAST

15.5. END-USERS

15.5.1. MARKET SIZE & FORECAST

15.6. KEY COUNTRIES

15.6.1. CHINA: MARKET SIZE & FORECAST

15.6.2. JAPAN: MARKET SIZE & FORECAST

15.6.3. INDIA: MARKET SIZE & FORECAST

15.6.4. SOUTH KOREA: MARKET SIZE & FORECAST

15.6.5. AUSTRALIA: MARKET SIZE & FORECAST

15.6.6. INDONESIA: MARKET SIZE & FORECAST

16 LATIN AMERICA

16.1. MARKET OVERVIEW

16.2. MARKET SIZE & FORECAST

16.3. PRODUCT

16.3.1. MARKET SIZE & FORECAST

16.4. APPLICATION

16.4.1. MARKET SIZE & FORECAST

16.5. END-USERS

16.5.1. MARKET SIZE & FORECAST

16.6. KEY COUNTRIES

16.6.1. BRAZIL: MARKET SIZE & FORECAST

16.6.2. MEXICO: MARKET SIZE & FORECAST

16.6.3. ARGENTINA: MARKET SIZE & FORECAST

17 MIDDLE EAST & AFRICA

17.1. MARKET OVERVIEW

17.2. MARKET SIZE & FORECAST

17.3. PRODUCT

17.3.1. MARKET SIZE & FORECAST

17.4. APPLICATION

17.4.1. MARKET SIZE & FORECAST

17.5. END-USERS

17.5.1. MARKET SIZE & FORECAST

17.6. KEY COUNTRIES

17.6.1. TURKEY: MARKET SIZE & FORECAST

17.6.2. SAUDI ARABIA: MARKET SIZE & FORECAST

17.6.3. SOUTH AFRICA: MARKET SIZE & FORECAST

17.6.4. UAE: MARKET SIZE & FORECAST

18 COMPETITIVE LANDSCAPE

18.1. COMPETITION OVERVIEW

18.2. MARKET SHARE ANALYSIS

18.2.1. ABBOTT

18.2.2. BIO-RAD LABORATORIES

18.2.3. BOULE

18.2.4. DANAHER

18.2.5. DIATRON

18.2.6. HORIBA

18.2.7. MERCK KGAA

18.2.8. PERKINELMER

18.2.9. SIEMENS HEALTHINEERS

18.2.10. SYSMEX CORPORATION

18.2.11. THERMO FISHER SCIENTIFIC

19 KEY COMPANY PROFILES

19.1. ABBOTT

19.1.1. BUSINESS OVERVIEW

19.1.2. PRODUCT OFFERINGS

19.1.3. KEY STRATEGIES

19.1.4. KEY STRENGTHS

19.1.5. KEY OPPORTUNITIES

19.2. BIO-RAD LABORATORIES

19.2.1. BUSINESS OVERVIEW

19.2.2. PRODUCT OFFERINGS

19.2.3. KEY STRATEGIES

19.2.4. KEY STRENGTHS

19.2.5. KEY OPPORTUNITIES

19.3. BOULE

19.3.1. BUSINESS OVERVIEW

19.3.2. PRODUCT OFFERINGS

19.3.3. KEY STRATEGIES

19.3.4. KEY STRENGTHS

19.3.5. KEY OPPORTUNITIES

19.4. DANAHER

19.4.1. BUSINESS OVERVIEW

19.4.2. PRODUCT OFFERINGS

19.4.3. KEY STRATEGIES

19.4.4. KEY STRENGTHS

19.4.5. KEY OPPORTUNITIES

19.5. DIATRON

19.5.1. BUSINESS OVERVIEW

19.5.2. PRODUCT OFFERINGS

19.5.3. KEY STRATEGIES

19.5.4. KEY STRENGTHS

19.5.5. KEY OPPORTUNITIES

19.6. HORIBA

19.6.1. BUSINESS OVERVIEW

19.6.2. PRODUCT OFFERINGS

19.6.3. KEY STRATEGIES

19.6.4. KEY STRENGTHS

19.6.5. KEY OPPORTUNITIES

19.7. MERCK KGAA

19.7.1. BUSINESS OVERVIEW

19.7.2. PRODUCT OFFERINGS

19.7.3. KEY STRATEGIES

19.7.4. KEY STRENGTHS

19.7.5. KEY OPPORTUNITIES

19.8. PERKINELMER

19.8.1. BUSINESS OVERVIEW

19.8.2. PRODUCT OFFERINGS

19.8.3. KEY STRATEGIES

19.8.4. KEY STRENGTHS

19.8.5. KEY OPPORTUNITIES

19.9. SIEMENS HEALTHINEERS

19.9.1. BUSINESS OVERVIEW

19.9.2. PRODUCT OFFERINGS

19.9.3. KEY STRATEGIES

19.9.4. KEY STRENGTHS

19.9.5. KEY OPPORTUNITIES

19.10. SYSMEX CORPORATION

19.10.1. BUSINESS OVERVIEW

19.10.2. PRODUCT OFFERINGS

19.10.3. KEY STRATEGIES

19.10.4. KEY STRENGTHS

19.10.5. KEY OPPORTUNITIES

19.11. THERMO FISHER SCIENTIFIC

19.11.1. BUSINESS OVERVIEW

19.11.2. PRODUCT OFFERINGS

19.11.3. KEY STRATEGIES

19.11.4. KEY STRENGTHS

19.11.5. KEY OPPORTUNITIES

20 OTHER PROMINENT VENDORS

20.1. ADVANCED INSTRUMENTS

20.1.1. BUSINESS OVERVIEW

20.1.2. PRODUCT OFFERINGS

20.2. AGILENT TECHNOLOGIES

20.2.1. BUSINESS OVERVIEW

20.2.2. PRODUCT OFFERINGS

20.3. AXION BIOSYSTEMS

20.3.1. BUSINESS OVERVIEW

20.3.2. PRODUCT OFFERINGS

20.4. ALIGNED GENETICS (LOGOS BIOSYSTEMS)

20.4.1. BUSINESS OVERVIEW

20.4.2. PRODUCT OFFERINGS

20.5. ALPHATEC SCIENTIFIC

20.5.1. BUSINESS OVERVIEW

20.5.2. PRODUCT OFFERINGS

20.6. AGAPPE DIAGNOSTICS

20.6.1. BUSINESS OVERVIEW

20.6.2. PRODUCT OFFERINGS

20.7. ANALYTICON BIOTECHNOLOGIES

20.7.1. BUSINESS OVERVIEW

20.7.2. PRODUCT OFFERINGS

20.8. BALIO DIAGNOSTICS

20.8.1. BUSINESS OVERVIEW

20.8.2. PRODUCT OFFERINGS

20.9. B&E BIO-TECHNOLOGY

20.9.1. BUSINESS OVERVIEW

20.9.2. PRODUCT OFFERINGS

20.10. BIOSYSTEMS DIAGNOSTICS

20.10.1. BUSINESS OVERVIEW

20.10.2. PRODUCT OFFERINGS

20.11. BIOWAY BIOLOGICAL TECHNOLOGY

20.11.1. BUSINESS OVERVIEW

20.11.2. PRODUCT OFFERINGS

20.12. BIOSYS SCIENTIFIC DEVICES GMBH

20.12.1. BUSINESS OVERVIEW

20.12.2. PRODUCT OFFERINGS

20.13. BENCHMARK SCIENTIFIC

20.13.1. BUSINESS OVERVIEW

20.13.2. PRODUCT OFFERINGS

20.14. BD

20.14.1. BUSINESS OVERVIEW

20.14.2. PRODUCT OFFERINGS

20.15. BRUKER SPATIAL BIOLOGY (NANOSTRING TECHNOLOGIES, INC.)

20.15.1. BUSINESS OVERVIEW

20.15.2. PRODUCT OFFERINGS

20.16. BENTLEY INSTRUMENTS

20.16.1. BUSINESS OVERVIEW

20.16.2. PRODUCT OFFERINGS

20.17. CHEMOMETEC

20.17.1. BUSINESS OVERVIEW

20.17.2. PRODUCT OFFERINGS

20.18. CORNING INCORPORATED

20.18.1. BUSINESS OVERVIEW

20.18.2. PRODUCT OFFERINGS

20.19. CURIOSIS INC

20.19.1. BUSINESS OVERVIEW

20.19.2. PRODUCT OFFERINGS

20.20. CYTEK BIOSCIENCES

20.20.1. BUSINESS OVERVIEW

20.20.2. PRODUCT OFFERINGS

20.21. COLE-PARMER INSTRUMENT COMPANY

20.21.1. BUSINESS OVERVIEW

20.21.2. PRODUCT OFFERINGS

20.22. CELLULAR TECHNOLOGY LTD (IMMUNOSPOT)

20.22.1. BUSINESS OVERVIEW

20.22.2. PRODUCT OFFERINGS

20.23. CLINDIAG SYSTEMS

20.23.1. BUSINESS OVERVIEW

20.23.2. PRODUCT OFFERINGS

20.24. CONTECH MEDICAL SYSTEMS

20.24.1. BUSINESS OVERVIEW

20.24.2. PRODUCT OFFERINGS

20.25. CONVERGENT TECHNOLOGIES

20.25.1. BUSINESS OVERVIEW

20.25.2. PRODUCT OFFERINGS

20.26. CPC DIAGNOSTICS

20.26.1. BUSINESS OVERVIEW

20.26.2. PRODUCT OFFERINGS

20.27. DIAGON

20.27.1. BUSINESS OVERVIEW

20.27.2. PRODUCT OFFERINGS

20.28. DIRUI

20.28.1. BUSINESS OVERVIEW

20.28.2. PRODUCT OFFERINGS

20.29. DRUCKER DIAGNOSTICS

20.29.1. BUSINESS OVERVIEW

20.29.2. PRODUCT OFFERINGS

20.30. DENOVIX

20.30.1. BUSINESS OVERVIEW

20.30.2. PRODUCT OFFERINGS

20.31. EDAN INSTRUMENTS

20.31.1. BUSINESS OVERVIEW

20.31.2. PRODUCT OFFERINGS

20.32. F. HOFFMAN-LA ROCHE

20.32.1. BUSINESS OVERVIEW

20.32.2. PRODUCT OFFERINGS

20.33. GENRUI BIOTECH

20.33.1. BUSINESS OVERVIEW

20.33.2. PRODUCT OFFERINGS

20.34. HIGH TECHNOLOGY

20.34.1. BUSINESS OVERVIEW

20.34.2. PRODUCT OFFERINGS

20.35. HOSPITEX INTERNATIONAL LTD

20.35.1. BUSINESS OVERVIEW

20.35.2. PRODUCT OFFERINGS

20.36. LINEAR CHEMICALS

20.36.1. BUSINESS OVERVIEW

20.36.2. PRODUCT OFFERINGS

20.37. MACCURA BIOTECHNOLOGY

20.37.1. BUSINESS OVERVIEW

20.37.2. PRODUCT OFFERINGS

20.38. MERIL LIFE SCIENCES

20.38.1. BUSINESS OVERVIEW

20.38.2. PRODUCT OFFERINGS

20.39. MEDSOURCE OZONE BIOMEDICALS

20.39.1. BUSINESS OVERVIEW

20.39.2. PRODUCT OFFERINGS

20.40. NIHON KODEN CORPORATION

20.40.1. BUSINESS OVERVIEW

20.40.2. PRODUCT OFFERINGS

20.41. NORMA INSTRUMENTS

20.41.1. BUSINESS OVERVIEW

20.41.2. PRODUCT OFFERINGS

20.42. NANOENTEK

20.42.1. BUSINESS OVERVIEW

20.42.2. PRODUCT OFFERINGS

20.43. PAUL MARIENFELD GMBH & CO. KG.

20.43.1. BUSINESS OVERVIEW

20.43.2. PRODUCT OFFERINGS

20.44. RWD LIFE SCIENCES CO LTD.

20.44.1. BUSINESS OVERVIEW

20.44.2. PRODUCT OFFERINGS

20.45. REVVITY

20.45.1. BUSINESS OVERVIEW

20.45.2. PRODUCT OFFERINGS

20.46. SARTORIUS AG

20.46.1. BUSINESS OVERVIEW

20.46.2. PRODUCT OFFERINGS

20.47. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS

20.47.1. BUSINESS OVERVIEW

20.47.2. PRODUCT OFFERINGS

20.48. SHENZHEN LANDWIND INDUSTRY

20.48.1. BUSINESS OVERVIEW

20.48.2. PRODUCT OFFERINGS

20.49. PRESTIGE DIAGNOSTICS

20.49.1. BUSINESS OVERVIEW

20.49.2. PRODUCT OFFERINGS

20.50. SFRI

20.50.1. BUSINESS OVERVIEW

20.50.2. PRODUCT OFFERINGS

20.51. SHENZHEN DYMIND BIOTECHNOLOGY

20.51.1. BUSINESS OVERVIEW

20.51.2. PRODUCT OFFERINGS

20.52. SHENZHEN PROKAN ELECTRONICS

20.52.1. BUSINESS OVERVIEW

20.52.2. PRODUCT OFFERINGS

20.53. SPINREACT

20.53.1. BUSINESS OVERVIEW

20.53.2. PRODUCT OFFERINGS

20.54. TRIVITRON HEALTHCARE.

20.54.1. BUSINESS OVERVIEW

20.54.2. PRODUCT OFFERINGS

20.55. TECAN TRADING AG

20.55.1. BUSINESS OVERVIEW

20.55.2. PRODUCT OFFERINGS

20.56. TIP BIOSYSTEMS

20.56.1. BUSINESS OVERVIEW

20.56.2. PRODUCT OFFERINGS

21 REPORT SUMMARY

21.1. KEY TAKEAWAYS

21.2. STRATEGIC RECOMMENDATIONS

22 QUANTITATIVE SUMMARY

22.1. MARKET BY GEOGRAPHY

22.2. MARKET BY-PRODUCTS

22.3. MARKET BY APPLICATION

22.4. MARKET BY END-USERS

23 APPENDIX

23.1. RESEARCH METHODOLOGY

23.2. RESEARCH PROCESS

23.3. REPORT ASSUMPTIONS & CAVEATS

23.3.1. KEY CAVEATS

23.3.2. CURRENCY CONVERSION

23.4. ABBREVIATIONS

Select a license type that suits your business needs

Single User Licence

$4200.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$4999.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$5999.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

What is the growth rate of the global cell counting devices market?

The global cell counting devices market is expected to grow at a CAGR of 7.04% from 2023 to 2029.

How big is the cell counting devices market?

The global cell counting devices market size was valued at USD 12.39 billion in 2023 and is expected to reach USD 18.64 billion by 2029.

What are the significant trends in the cell counting devices industry?

Technology advancements in cell counting devices, increasing application areas for cell counting devices, and the rising focus on flow cytometry in cell counting are significant trends in the cell counting devices industry.

Which region dominates the global cell counting devices market share?

North America held the largest global cell counting devices market share, accounting for a share of over 36% in 2023.

Who are the key players in the global cell counting devices market?

Abbott, Bio-Rad Laboratories, Boule, Danaher, Diatron, HORIBA, Merck KGaA, PerkinElmer, Siemens Healthineers, Sysmex Corporation, and Thermo Fisher Scientific are the key players in the global cell counting devices market.